Disclaimer
We’re actively expanding Guideline Genius to cover the full UKMLA content map. You may notice some conditions not uploaded yet, or articles that only include diagnosis and management for now. For updates, follow us on Instagram @guidelinegenius.
We openly welcome any feedback or suggestions through the anonymous feedback box at the bottom of every article and we’ll do our best to respond promptly.

Thank you for your support.
The Guideline Genius Team

Total Live Articles: 326

Perioperative Medicine Management

NICE BNF Treatment summaries. Surgery and long-term medications

NICE BNF Treatment summaries. Diabetes, surgery and medical illness

UK Clinical Pharmacy Association – Handbook of Perioperative Medicines

Changes have been made to the Pre-Operative Management of Diabetes Mellitus section to optimise the content quality.

Date: 26/01/26

Changes to Medications Before Elective Surgery

Nil By Mouth (NBM)

Minimum fasting times for elective surgery (6-4-2):

  • 6 hours for solid food
  • 4 hours for breast milk
  • 2 hours for clear fluids (e.g. water, tea / coffee without milk)

 

Note that being NBM is not a reason to omit regular oral medications; they can be given with a sip of water up to the time of surgery. See below for what oral medications need to be stopped.

Medications to Discontinue

The following are derived from a combination of both the BNF and the Handbook of Perioperative Medicines by the UK Clinical Pharmacy Association

  • The BNF provides clear, specific guidance on the management of oestrogen-containing medications, ACE inhibitors/ARBs, lithium, and diabetes medications prior to surgery, so it is important to be familiar with these recommendations.
  • For other drug classes, particularly antithrombotic agents (antiplatelets and anticoagulants), the BNF does not offer specific instructions. Instead, it advises that the anaesthetist and surgeon should jointly assess the patient’s individual risks and make case-by-case decisions about interruption or bridging (e.g., switching to heparin) based on both clinical and procedural factors.
  • When not specifically mentioned in the BNF, information is derived from the Handbook of Perioperative Medicines

This is NOT an exhaustive list; always refer to local guidelines / protocol.

Medication category Specific medications Changes to medicine Rationale
Oestrogen-containing medications COCP

 

* Discontinuation only recommended for oestrogen-containing contraception

* Progesterone only hormonal contraception can be continued/started preoperatively (no increased thrombotic risk)

Stop 4 weeks before surgery Due to the increased risk of VTE from the oestrogen
HRT
Cardiovascular medications ACE inhibitor / ARB Stop 24 hours before surgery Due to the increased risk of hypotension
Potassium-sparing diuretic May need to be stopped on the morning of surgery Due to the increased risk of hyperkalaemia if renal perfusion is impaired or if there is tissue damage
Other cardiovascular drugs like beta blockers, calcium channel blockers, and statins do NOT need to be stopped routinely before surgery.
Antiplatelets Aspirin If aspirin is used for analgesia → stop 7 days before surgery

If aspirin is used as an antiplatelet, it should generally be stopped 7 days before surgery, and take the following into consideration:

  • Aspirin should be continued if there is a high thrombotic risk (e.g. recent acute coronary syndrome, coronary artery stents, or an ischaemic stroke)
  • Stop in procedures with a high bleeding risk / complications (e.g. spinal surgery, some ophthalmological and neurosurgical procedures)
  • Stop in individuals who refuse blood transfusion (eg. Jehovah’s Witness)

International guidelines: aspirin should be stopped before surgery for primary prevention, but continued for secondary prevention

Due to the increased risk of bleeding
P2Y12 inhibitors Clopidogrel / prasugrel: stop 7 days before surgery

 

Ticagrelor: stop 5 days before surgery

Anticoagulants Warfarin Stop 5 days before surgery

 

Bridging with heparin is necessary for those at high thromboembolic risk

LMWH (e.g. enoxaparin, dalteparin) Stop 12 hours (prophylactic dose) / 24 hours (treatment dose) before surgery
DOACs (e.g. apixaban, rivaroxaban, edoxaban)* If patient is on DOAC due to recent DVT / PE → consult haematology

 

Otherwise, it depends on bleeding risk of surgery / procedure

  • Low-risk endoscopic procedures: omit morning dose
  • Moderate risk: stop 24 hours before surgery
  • High risk: stop 48 hours before surgery
Psychiatric medications Lithium Stop 24 hours before major surgery

Otherwise, it can be continued for minor surgery

Due to its interaction with muscle relaxants (potentiates their effect) and the risk of lithium toxicity
Clozapine Stop 12 hours before surgery To minimise the risk of hypotension and sedation without risking relapse
Diabetes medications See separate section below

*Decisions regarding stopping anticoagulants are more complicated, require individualisation and balancing between the indications for anticoagulation and risk of bleeding. Therefore, certain details are omitted for educational purposes.

Generally, when it comes to stopping antiplatelets or anticoagulants before elective surgeries, the decision is not that clean-cut.

Medications to Increase / Continue as Normal

People on long-term steroids (for adrenal insufficiency or other reasons) should receive ‘stress’ glucocorticoid doses to prevent adrenal crisis during surgery (a stress event)

  • When patients are NBM, switch to IV hydrocortisone at stress doses (usually double the daily dose)

 

Otherwise, the BNF advised specifically that the following drugs should NOT be stopped before surgery:

  • Antiepileptics
  • Antiparkinsonian drugs
  • Antipsychotics
  • Anxiolytics
  • Bronchodilators
  • Cardiovascular drugs (apart from ACE inhibitors / ARBs / potassium-sparing diuretics, mentioned above)
  • Glaucoma drugs
  • Immunosuppressants
  • Drugs of dependence
  • Thyroid / antithyroid drugs

Pre-Operative Management of Diabetes Mellitus

Emergency Surgery

Most people with diabetes (type 1 and 2) requiring emergency surgery should receive VRIII protocol (regardless of whether they are taking insulin or not)

 

Regarding changes to other medications, it is the same as those for elective surgery, summarised here:

  • If the patient takes insulin → continue long-acting insulin at 80% normal dose + stop any other insulin
  • If patients take oral medications
    • Stop sulfonylurea + SGLT-2 inhibitors
    • Stop metformin if >1 meal will be missed or at significant risk of developing AKI (eGFR <60 or procedure involves use of contrast media)
    • Other diabetic drugs can be continued (DPP-4 inhibitors, pioglitazone, GLP-1 agonist)

Elective Surgery

Patients Who Only Take Oral Medications

In patients who only take oral medications (i.e. most type 2 diabetes patients), there are 2 things to consider:

  1. Changes to regular oral medications
  2. Whether starting VRIII protocol is necessary or not

1. Changes to Regular Oral Medications

The key concept here is: ALWAYS take the drugs normally before admission, ONLY make any changes on the day of surgery

Drug Changes prior to surgery
Metformin Omit the metformin on the day if:*
  • >1 meal will be missed​​​​​​, or
  • Patient is at significant risk of developing AKI (eGFR <60 or procedure involves use of contrast media)

Such that, it is possible to continue metformin (and just omitting the lunchtime dose if prescribed TDS) if 1) only 1 meal will be missed, 2) eGFR >60, and 3) low risk of AKI.

* This is due to the increased risk of lactic acidosis intra-operatively and post-operatively (as the patient would be relatively dehydrated and surgery is a stressful event)

Sulfonylurea NB sulfonylureas carry a significant risk of hypoglycaemia:
  • Day of surgery (morning operation) → omit morning dose
  • Day of surgery (afternoon operation) → omit morning and afternoon dose
SGLT-2 inhibitors Omit on the day (due to risk of DKA)
Pioglitazone Take as normal (no need to omit)
DPP-4 inhibitors
GLP-1 agonist*

*One might encounter a source saying that GLP-1 agonists should be stopped 1 week before surgery (endorsed by US guidelines), due to the increased risk of aspiration (GLP-1 agonists delay gastric emptying). However, both the BNF and Association of Anaesthetists (Jan 2025) advise that GLP-1 or dual GIP/GLP-1 receptor agonists can be taken as normal before surgeries. [Ref]

2. Whether Starting VRIII is Necessary or Not

The VRIII protocol should be started if (ANY):

  • Patient undergoing a major procedure (i.e. long fasting period causing >1 missed meal)
  • Patient with suboptimal diabetes management (defined as HbA1c >69 mmol/mol or >8.5%)
  • Patients with persistent pre-operative hyperglycaemia (defined as capillary blood glucose >12 mmol/L) (usually in the context of acute decompensation)

Patients Who Take Insulin

Pre-Op – Management of Insulin Therapy

Pre-op management largely depends on 1) procedure type (minor vs major) and 2) glycemic control (good vs poor)

Procedure type definitions
  • Minor procedure: no fasting required / only 1 meal to be missed (e.g. cataract surgery, endoscopies, laparoscopy surgeries)
  • Major procedure: long fasting period causing >1 missed meal
Glycaemic control definitions
  • Good control: HbA1c <69 mmol/mol (8.5%)
  • Poor control: HbA1c >69 mmol/mol (8.5%)

Based on the above factors, there are 2 scenarios.

Good Glycaemic Control AND Undergoing a Minor Procedure

There is NO need to give additional insulin (i.e. VRIII protocol) in these patients; they can be managed by adjusting their usual insulin regimen on the day before surgery:

  • Once-daily long-acting insulin → give 80% of the usual dose (20% dose reduction)
  • All other insulin → give as normal
Poor Glycaemic Control OR Undergoing a Major Procedure

These patients require additional insulin, the exact steps are:

Phase Action
The day before surgery
  • Once-daily long-acting insulin → give 80% of the usual dose (20% dose reduction)
  • All other insulin → give as normal
On the day of surgery
  • Continue long-acting insulin at 80% of the usual dose + stop all other insulin, and
  • Start VRIII protocol

Post-Op – Converting Back to Normal (Subcutaneous) Insulin

Conversion back to normal subcutaneous insulin should NOT begin until the patient is eating and drinking without nausea and vomiting.

There are 3 main scenarios:

Scenario (depends on the patient’s previous insulin regimen) Conversion
Basal-bolus regimen (the typical T1DM regimen)
  • Restart subcutaneous short-acting insulin when 1st post-op meal time insulin dose is due
  • Continue the VRIII protocol until 30-60 min after the 1st insulin dose is given
  • The long-acting insulin can be continued (as it should not have been stopped)
Twice-daily mixed insulin regimen
  • Restart before breakfast or dinner (not at any other time)
  • Continue the VRIII protocol until 30-60 min after the 1st insulin dose is given
Once-daily long-acting insulin
  • Continue the 80% dose as normal, resume the normal dose once the patient leaves the hospital

Remember, once-daily long-acting insulin does NOT need to be stopped pre-op (only dose reduction)

References

Share Your Feedback Below

UK medical guidelines made easy. From guidelines to genius in minutes!

Quick Links

Cookie Policy

Social Media

© 2026 GUIDELINE GENIUS LTD